Abstract

Although it is clear that trisomy 21 causes Down syndrome, the molecular events acting downstream of the trisomy remain ill defined. Using complementary genomics analyses, we identified the interferon pathway as the major signaling cascade consistently activated by trisomy 21 in human cells. Transcriptome analysis revealed that trisomy 21 activates the interferon transcriptional response in fibroblast and lymphoblastoid cell lines, as well as circulating monocytes and T cells. Trisomy 21 cells show increased induction of interferon-stimulated genes and decreased expression of ribosomal proteins and translation factors. An shRNA screen determined that the interferon-activated kinases JAK1 and TYK2 suppress proliferation of trisomy 21 fibroblasts, and this defect is rescued by pharmacological JAK inhibition. Therefore, we propose that interferon activation, likely via increased gene dosage of the four interferon receptors encoded on chromosome 21, contributes to many of the clinical impacts of trisomy 21, and that interferon antagonists could have therapeutic benefits.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Kelly D Sullivan

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    For correspondence
    kelly.d.sullivan@ucdenver.edu
    Competing interests
    No competing interests declared.
  2. Hannah C Lewis

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  3. Amanda A Hill

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  4. Ahwan Pandey

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  5. Leisa P Jackson

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  6. Joseph M Cabral

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  7. Keith P Smith

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  8. L Alexander Liggett

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  9. Eliana B Gomez

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  10. Matthew D Galbraith

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  11. James DeGregori

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    Competing interests
    No competing interests declared.
  12. Joaquín M Espinosa

    Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States
    For correspondence
    joaquin.espinosa@ucdenver.edu
    Competing interests
    Joaquín M Espinosa, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9048-1941

Funding

Linda Crnic Institute for Down Syndrome

  • Joaquín M Espinosa

Howard Hughes Medical Institute

  • Joaquín M Espinosa

National Institutes of Health (R01CA117907, P30CA046934-27)

  • Joaquín M Espinosa

National Science Foundation (MCB-1243522)

  • Joaquín M Espinosa

Anna and John J. Sie Foundation

  • Joaquín M Espinosa

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Christopher K Glass, University of California, San Diego, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the University of Colorado. The protocol was approved by the University of Colorado IACUC (Protocol Number: B-41413(04)1E).

Human subjects: All individuals in this study were consented on Colorado Multiple Institutional Review Board (COMIRB)-approved protocols (Protocol Numbers: 11-1790 or 15-1774) and samples collected and processed as describe in the Materials and Methods.

Version history

  1. Received: March 19, 2016
  2. Accepted: July 28, 2016
  3. Accepted Manuscript published: July 29, 2016 (version 1)
  4. Version of Record published: September 6, 2016 (version 2)

Copyright

© 2016, Sullivan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 9,215
    Page views
  • 1,448
    Downloads
  • 189
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Kelly D Sullivan
  2. Hannah C Lewis
  3. Amanda A Hill
  4. Ahwan Pandey
  5. Leisa P Jackson
  6. Joseph M Cabral
  7. Keith P Smith
  8. L Alexander Liggett
  9. Eliana B Gomez
  10. Matthew D Galbraith
  11. James DeGregori
  12. Joaquín M Espinosa
(2016)
Trisomy 21 consistently activates the interferon response
eLife 5:e16220.
https://doi.org/10.7554/eLife.16220

Share this article

https://doi.org/10.7554/eLife.16220

Further reading

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Lucie Crhak Khaitova, Pavlina Mikulkova ... Karel Riha
    Research Article

    Heat stress is a major threat to global crop production, and understanding its impact on plant fertility is crucial for developing climate-resilient crops. Despite the known negative effects of heat stress on plant reproduction, the underlying molecular mechanisms remain poorly understood. Here, we investigated the impact of elevated temperature on centromere structure and chromosome segregation during meiosis in Arabidopsis thaliana. Consistent with previous studies, heat stress leads to a decline in fertility and micronuclei formation in pollen mother cells. Our results reveal that elevated temperature causes a decrease in the amount of centromeric histone and the kinetochore protein BMF1 at meiotic centromeres with increasing temperature. Furthermore, we show that heat stress increases the duration of meiotic divisions and prolongs the activity of the spindle assembly checkpoint during meiosis I, indicating an impaired efficiency of the kinetochore attachments to spindle microtubules. Our analysis of mutants with reduced levels of centromeric histone suggests that weakened centromeres sensitize plants to elevated temperature, resulting in meiotic defects and reduced fertility even at moderate temperatures. These results indicate that the structure and functionality of meiotic centromeres in Arabidopsis are highly sensitive to heat stress, and suggest that centromeres and kinetochores may represent a critical bottleneck in plant adaptation to increasing temperatures.

    1. Chromosomes and Gene Expression
    Allison Coté, Aoife O'Farrell ... Arjun Raj
    Research Article

    Splicing is the stepwise molecular process by which introns are removed from pre-mRNA and exons are joined together to form mature mRNA sequences. The ordering and spatial distribution of these steps remain controversial, with opposing models suggesting splicing occurs either during or after transcription. We used single-molecule RNA FISH, expansion microscopy, and live-cell imaging to reveal the spatiotemporal distribution of nascent transcripts in mammalian cells. At super-resolution levels, we found that pre-mRNA formed clouds around the transcription site. These clouds indicate the existence of a transcription-site-proximal zone through which RNA move more slowly than in the nucleoplasm. Full-length pre-mRNA undergo continuous splicing as they move through this zone following transcription, suggesting a model in which splicing can occur post-transcriptionally but still within the proximity of the transcription site, thus seeming co-transcriptional by most assays. These results may unify conflicting reports of co-transcriptional versus post-transcriptional splicing.